Range Land was Range Impact’s largest revenue line in fiscal 2025, bringing in $2.71M of $3.71M (73%).
| Operating Activities | FY 2018 | FY 2019 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|
| Range Reclaim | $4.83M | $18.66M | $4.68M | — | ||
| Range Minerals | — | — | $3.42M | — | ||
| Range Land | — | — | — | $2.71M | ||
| Corporate | — | — | — | $1.00M | ||
| Range Security | — | $684.20K | $918.36K | — | ||
| Clinical Operations | — | — | — | — | ||
| Pharmacuetical Operations | — | — | — | — | ||
| Total | $4.83M | $19.35M | $9.01M | $3.71M |
Range Impact brought in $3.71M from its two revenue lines in fiscal 2025, the year ended December 31, 2025. Range Impact regrouped these revenue lines after fiscal 2024, so the total does not compare directly with that year's $9.01M. Range Land was the largest at $2.71M (73.1%), ahead of Corporate at $1.00M (26.9%).
Range Impact began breaking out Range Land in fiscal 2025 and Corporate in fiscal 2025. Range Impact stopped reporting Range Reclaim ($4.68M in fiscal 2024), Range Minerals ($3.42M in fiscal 2024) and Range Security ($918.36K in fiscal 2024) as separate revenue lines.
Transferred At Point In Time was Range Impact’s largest revenue line in fiscal 2024, bringing in $6.95M of $9.01M (77%).
| Timing of Transfer of Good or Service | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|
| Transferred At Point In Time | $4.83M | $16.52M | $6.95M |
| Transferred Over Time | — | $2.82M | $2.06M |
| Total | $4.83M | $19.35M | $9.01M |
Range Impact brought in $9.01M from its two revenue lines in fiscal 2024, the year ended December 31, 2024. That was down 53.4% from $19.35M in fiscal 2023. Transferred At Point In Time was the largest at $6.95M (77.1%), ahead of Transferred Over Time at $2.06M (22.9%).
Compared with fiscal 2023, Transferred Over Time fell 27.1% to $2.06M and Transferred At Point In Time fell 57.9% to $6.95M.
Range Impact began breaking out Transferred Over Time in fiscal 2023, when it brought in $2.82M.
Clinical Operations was Range Impact’s largest product and service line in fiscal 2019, bringing in $150.92K of $258.29K (58%).
| Product and Service | FY 2018 | FY 2019 |
|---|---|---|
| Clinical Operations | — | $150.92K |
| Pharmaceutical Operations | $102.42K | $107.37K |
| Total | $102.42K | $258.29K |
Range Impact brought in $258.29K from its two product and service lines in fiscal 2019, the year ended March 31, 2019. Range Impact regrouped these lines after fiscal 2018, so the total does not compare directly with that year's $102.42K. Clinical Operations was the largest at $150.92K (58.4%), ahead of Pharmaceutical Operations at $107.37K (41.6%).
Range Impact began breaking out Clinical Operations in fiscal 2019, when it brought in $150.92K.
Range Impact (RNGE) reports its revenue by operating activities, by timing of transfer of good or service and by product and service. In fiscal 2025, Range Land was its largest revenue line, bringing in $2.71M (73.1% of the total), followed by Corporate at $1.00M (26.9%).
Range Land was Range Impact's largest revenue line in fiscal 2025, bringing in $2.71M, or 73.1% of the $3.71M total across its two revenue lines.
Clinical Operations was Range Impact's largest product and service line in fiscal 2019, bringing in $150.92K, or 58.4% of the $258.29K total across its two product and service lines.
Every figure comes from Range Impact's annual financial filings, as reported. Each line keeps the name Range Impact gives it, and years follow its fiscal calendar.
Range Impact's revenue by operating activities goes back to fiscal 2018, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.